Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 12 March, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 533022 | NSE: 20MICRONS

20 Microns Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 10, 2025, 11:32 am

Market Cap 737 Cr.
Current Price 209
High / Low 348/131
Stock P/E12.0
Book Value 109
Dividend Yield0.60 %
ROCE21.7 %
ROE17.8 %
Face Value 5.00
PEG Ratio0.56

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for 20 Microns Ltd

Competitors of 20 Microns Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Ganesha Ecoverse Ltd 82.8 Cr. 33.6 62.6/32.215.2 4.290.00 %28.2 %39.4 % 10.0
Foundry Fuel Products Ltd 4.25 Cr. 5.30 14.6/5.30 1.350.00 %%% 10.0
Deccan Gold Mines Ltd 1,555 Cr. 100 179/88.5 14.20.00 %8.77 %34.8 % 1.00
Asi Industries Ltd 300 Cr. 33.3 65.9/22.310.3 35.91.05 %10.1 %7.47 % 1.00
Anmol India Ltd 97.2 Cr. 17.1 53.0/15.010.4 18.40.00 %14.9 %23.6 % 10.0
Industry Average40,340.77 Cr586.6464.2874.501.80%21.11%21.07%5.18

All Competitor Stocks of 20 Microns Ltd

Quarterly Result

MetricDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Sales 161172186188155173191200175212231240215
Expenses 138150161164138153164170153186201209188
Operating Profit 23222523172126302227303126
OPM % 14%13%13%12%11%12%14%15%13%12%13%13%12%
Other Income 0111101002211
Interest 4445444445445
Depreciation 3433343344455
Profit before tax 16151816101320221519242317
Tax % 26%27%25%26%27%29%25%28%25%29%26%27%23%
Net Profit 121113127915161214181613
EPS in Rs 3.303.013.763.362.092.644.234.543.253.875.064.653.65

Last Updated: March 3, 2025, 5:49 pm

Below is a detailed analysis of the quarterly data for 20 Microns Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

  • For Sales, as of Dec 2024, the value is ₹215.00 Cr.. The value appears to be declining and may need further review. It has decreased from 240.00 Cr. (Sep 2024) to ₹215.00 Cr., marking a decrease of 25.00 Cr..
  • For Expenses, as of Dec 2024, the value is ₹188.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 209.00 Cr. (Sep 2024) to ₹188.00 Cr., marking a decrease of 21.00 Cr..
  • For Operating Profit, as of Dec 2024, the value is ₹26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 31.00 Cr. (Sep 2024) to ₹26.00 Cr., marking a decrease of 5.00 Cr..
  • For OPM %, as of Dec 2024, the value is 12.00%. The value appears to be declining and may need further review. It has decreased from 13.00% (Sep 2024) to 12.00%, marking a decrease of 1.00%.
  • For Other Income, as of Dec 2024, the value is ₹1.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 1.00 Cr..
  • For Interest, as of Dec 2024, the value is ₹5.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.00 Cr. (Sep 2024) to ₹5.00 Cr., marking an increase of ₹1.00 Cr..
  • For Depreciation, as of Dec 2024, the value is ₹5.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 5.00 Cr..
  • For Profit before tax, as of Dec 2024, the value is ₹17.00 Cr.. The value appears to be declining and may need further review. It has decreased from 23.00 Cr. (Sep 2024) to ₹17.00 Cr., marking a decrease of 6.00 Cr..
  • For Tax %, as of Dec 2024, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Sep 2024) to 23.00%, marking a decrease of 4.00%.
  • For Net Profit, as of Dec 2024, the value is ₹13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16.00 Cr. (Sep 2024) to ₹13.00 Cr., marking a decrease of 3.00 Cr..
  • For EPS in Rs, as of Dec 2024, the value is 3.65. The value appears to be declining and may need further review. It has decreased from ₹4.65 (Sep 2024) to 3.65, marking a decrease of ₹1.00.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 9:26 pm

MetricMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales 312327356357392427480529484613702777898
Expenses 273297326310337367411463425534616672784
Operating Profit 3931304656606966597986106114
OPM % 12%9%8%13%14%14%14%12%12%13%12%14%13%
Other Income -5244212322325
Interest 18242725242222222520181618
Depreciation 8111110101010131414141417
Profit before tax 8-2-314232838352248577783
Tax % 37%19%-16%24%31%32%35%30%-6%27%27%27%
Net Profit 5-2-211161925242335425661
EPS in Rs 1.51-0.68-0.743.114.495.347.086.846.519.8011.8515.8917.23
Dividend Payout % 33%0%0%0%0%14%0%9%0%0%6%8%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)-140.00%0.00%650.00%45.45%18.75%31.58%-4.00%-4.17%52.17%20.00%33.33%
Change in YoY Net Profit Growth (%)0.00%140.00%650.00%-604.55%-26.70%12.83%-35.58%-0.17%56.34%-32.17%13.33%

20 Microns Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:9%
5 Years:10%
3 Years:17%
TTM:22%
Compounded Profit Growth
10 Years:49%
5 Years:18%
3 Years:35%
TTM:17%
Stock Price CAGR
10 Years:19%
5 Years:52%
3 Years:37%
1 Year:35%
Return on Equity
10 Years:14%
5 Years:15%
3 Years:16%
Last Year:18%

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 1:48 am

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 16171718181818181818181818
Reserves 53575470107126150170197234276335366
Borrowings 165177165163152134124119104123108121131
Other Liabilities 607798838698112137133140121114156
Total Liabilities 294328333334363376404444452514523588671
Fixed Assets 152158151151177185195201203207213212240
CWIP 497478411358125
Investments 111123426991717
Other Assets 137160174178177179201230240293293347409
Total Assets 294328333334363376404444452514523588671

Below is a detailed analysis of the balance sheet data for 20 Microns Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2024, the value is ₹18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹18.00 Cr..
  • For Reserves, as of Sep 2024, the value is ₹366.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹335.00 Cr. (Mar 2024) to ₹366.00 Cr., marking an increase of 31.00 Cr..
  • For Borrowings, as of Sep 2024, the value is ₹131.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹121.00 Cr. (Mar 2024) to ₹131.00 Cr., marking an increase of 10.00 Cr..
  • For Other Liabilities, as of Sep 2024, the value is ₹156.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹114.00 Cr. (Mar 2024) to ₹156.00 Cr., marking an increase of 42.00 Cr..
  • For Total Liabilities, as of Sep 2024, the value is ₹671.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹588.00 Cr. (Mar 2024) to ₹671.00 Cr., marking an increase of 83.00 Cr..
  • For Fixed Assets, as of Sep 2024, the value is ₹240.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹212.00 Cr. (Mar 2024) to ₹240.00 Cr., marking an increase of 28.00 Cr..
  • For CWIP, as of Sep 2024, the value is ₹5.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹12.00 Cr. (Mar 2024) to ₹5.00 Cr., marking a decrease of 7.00 Cr..
  • For Investments, as of Sep 2024, the value is ₹17.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹17.00 Cr..
  • For Other Assets, as of Sep 2024, the value is ₹409.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹347.00 Cr. (Mar 2024) to ₹409.00 Cr., marking an increase of 62.00 Cr..
  • For Total Assets, as of Sep 2024, the value is ₹671.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹588.00 Cr. (Mar 2024) to ₹671.00 Cr., marking an increase of 83.00 Cr..

Notably, the Reserves (₹366.00 Cr.) exceed the Borrowings (131.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +453730254461534552356354
Cash from Investing Activity +-39-21-4-6-9-18-19-16-9-23-18-23
Cash from Financing Activity +-7-14-21-26-34-44-33-30-45-4-38-3
Net Cash Flow-116-62-12-1-29828

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow-126.00-146.00-135.00-117.00-96.00-74.00-55.00-53.00-45.00-44.00-22.00-15.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days626551575657535768605159
Inventory Days11113412615013313213412814414811599
Days Payable761121381181051131061151341137954
Cash Conversion Cycle9687399084778069789487104
Working Capital Days554747726659606373867888
ROCE %15%10%9%16%18%19%21%19%15%19%19%22%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
Promoters44.83%44.83%44.83%44.83%44.83%44.83%44.83%44.95%44.95%44.95%44.95%44.99%
FIIs0.46%1.07%0.70%1.02%0.73%0.93%0.72%0.72%0.72%0.73%0.78%1.00%
DIIs0.00%0.00%0.00%0.13%0.13%0.00%0.00%0.00%0.00%0.00%0.06%0.02%
Public54.71%54.10%54.47%54.03%54.31%54.23%54.45%54.33%54.33%54.32%54.21%53.99%
No. of Shareholders18,25925,06423,75923,01122,44422,33622,33219,76820,54622,49226,05731,992

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 5.005.005.005.005.00
Basic EPS (Rs.) 15.8911.859.806.516.83
Diluted EPS (Rs.) 15.8911.859.806.516.83
Cash EPS (Rs.) 19.9415.7813.7210.4410.40
Book Value[Excl.RevalReserv]/Share (Rs.) 100.3583.5071.5360.9953.43
Book Value[Incl.RevalReserv]/Share (Rs.) 100.3583.5071.5360.9953.43
Revenue From Operations / Share (Rs.) 220.34198.85173.78137.03150.01
PBDIT / Share (Rs.) 30.9525.1323.1117.2919.44
PBIT / Share (Rs.) 26.8821.2219.2413.3715.89
PBT / Share (Rs.) 21.7716.1813.506.179.79
Net Profit / Share (Rs.) 15.8711.879.856.526.85
NP After MI And SOA / Share (Rs.) 15.8911.859.806.516.83
PBDIT Margin (%) 14.0412.6313.2912.6212.95
PBIT Margin (%) 12.1910.6611.079.7610.59
PBT Margin (%) 9.888.137.764.506.52
Net Profit Margin (%) 7.205.965.664.754.56
NP After MI And SOA Margin (%) 7.215.955.644.754.55
Return on Networth / Equity (%) 15.8814.2413.7510.7112.84
Return on Capital Employeed (%) 23.6921.7521.9017.7921.36
Return On Assets (%) 9.507.986.715.075.42
Long Term Debt / Equity (X) 0.030.060.110.110.20
Total Debt / Equity (X) 0.320.340.470.400.55
Asset Turnover Ratio (%) 1.401.231.141.021.22
Current Ratio (X) 1.751.531.331.231.19
Quick Ratio (X) 1.160.880.700.680.65
Inventory Turnover Ratio (X) 3.652.922.852.633.34
Dividend Payout Ratio (NP) (%) 4.720.000.000.008.77
Dividend Payout Ratio (CP) (%) 3.750.000.000.005.77
Earning Retention Ratio (%) 95.280.000.000.0091.23
Cash Earning Retention Ratio (%) 96.250.000.000.0094.23
Interest Coverage Ratio (X) 6.634.994.032.403.19
Interest Coverage Ratio (Post Tax) (X) 4.503.362.721.902.12
Enterprise Value (Cr.) 563.53334.96365.34200.94187.26
EV / Net Operating Revenue (X) 0.720.470.590.410.35
EV / EBITDA (X) 5.163.784.483.292.73
MarketCap / Net Operating Revenue (X) 0.650.370.420.250.17
Retention Ratios (%) 95.270.000.000.0091.22
Price / BV (X) 1.440.891.040.570.48
Price / Net Operating Revenue (X) 0.650.370.420.250.17
EarningsYield 0.110.150.130.180.26

After reviewing the key financial ratios for 20 Microns Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 5.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 15.89. This value is within the healthy range. It has increased from 11.85 (Mar 23) to 15.89, marking an increase of 4.04.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 15.89. This value is within the healthy range. It has increased from 11.85 (Mar 23) to 15.89, marking an increase of 4.04.
  • For Cash EPS (Rs.), as of Mar 24, the value is 19.94. This value is within the healthy range. It has increased from 15.78 (Mar 23) to 19.94, marking an increase of 4.16.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 100.35. It has increased from 83.50 (Mar 23) to 100.35, marking an increase of 16.85.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 100.35. It has increased from 83.50 (Mar 23) to 100.35, marking an increase of 16.85.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 220.34. It has increased from 198.85 (Mar 23) to 220.34, marking an increase of 21.49.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 30.95. This value is within the healthy range. It has increased from 25.13 (Mar 23) to 30.95, marking an increase of 5.82.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 26.88. This value is within the healthy range. It has increased from 21.22 (Mar 23) to 26.88, marking an increase of 5.66.
  • For PBT / Share (Rs.), as of Mar 24, the value is 21.77. This value is within the healthy range. It has increased from 16.18 (Mar 23) to 21.77, marking an increase of 5.59.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 15.87. This value is within the healthy range. It has increased from 11.87 (Mar 23) to 15.87, marking an increase of 4.00.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 15.89. This value is within the healthy range. It has increased from 11.85 (Mar 23) to 15.89, marking an increase of 4.04.
  • For PBDIT Margin (%), as of Mar 24, the value is 14.04. This value is within the healthy range. It has increased from 12.63 (Mar 23) to 14.04, marking an increase of 1.41.
  • For PBIT Margin (%), as of Mar 24, the value is 12.19. This value is within the healthy range. It has increased from 10.66 (Mar 23) to 12.19, marking an increase of 1.53.
  • For PBT Margin (%), as of Mar 24, the value is 9.88. This value is below the healthy minimum of 10. It has increased from 8.13 (Mar 23) to 9.88, marking an increase of 1.75.
  • For Net Profit Margin (%), as of Mar 24, the value is 7.20. This value is within the healthy range. It has increased from 5.96 (Mar 23) to 7.20, marking an increase of 1.24.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is 7.21. This value is below the healthy minimum of 8. It has increased from 5.95 (Mar 23) to 7.21, marking an increase of 1.26.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 15.88. This value is within the healthy range. It has increased from 14.24 (Mar 23) to 15.88, marking an increase of 1.64.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 23.69. This value is within the healthy range. It has increased from 21.75 (Mar 23) to 23.69, marking an increase of 1.94.
  • For Return On Assets (%), as of Mar 24, the value is 9.50. This value is within the healthy range. It has increased from 7.98 (Mar 23) to 9.50, marking an increase of 1.52.
  • For Long Term Debt / Equity (X), as of Mar 24, the value is 0.03. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 23) to 0.03, marking a decrease of 0.03.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.32. This value is within the healthy range. It has decreased from 0.34 (Mar 23) to 0.32, marking a decrease of 0.02.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 1.40. It has increased from 1.23 (Mar 23) to 1.40, marking an increase of 0.17.
  • For Current Ratio (X), as of Mar 24, the value is 1.75. This value is within the healthy range. It has increased from 1.53 (Mar 23) to 1.75, marking an increase of 0.22.
  • For Quick Ratio (X), as of Mar 24, the value is 1.16. This value is within the healthy range. It has increased from 0.88 (Mar 23) to 1.16, marking an increase of 0.28.
  • For Inventory Turnover Ratio (X), as of Mar 24, the value is 3.65. This value is below the healthy minimum of 4. It has increased from 2.92 (Mar 23) to 3.65, marking an increase of 0.73.
  • For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 4.72. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 4.72, marking an increase of 4.72.
  • For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 3.75. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 3.75, marking an increase of 3.75.
  • For Earning Retention Ratio (%), as of Mar 24, the value is 95.28. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 95.28, marking an increase of 95.28.
  • For Cash Earning Retention Ratio (%), as of Mar 24, the value is 96.25. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 96.25, marking an increase of 96.25.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 6.63. This value is within the healthy range. It has increased from 4.99 (Mar 23) to 6.63, marking an increase of 1.64.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 4.50. This value is within the healthy range. It has increased from 3.36 (Mar 23) to 4.50, marking an increase of 1.14.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 563.53. It has increased from 334.96 (Mar 23) to 563.53, marking an increase of 228.57.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.72. This value is below the healthy minimum of 1. It has increased from 0.47 (Mar 23) to 0.72, marking an increase of 0.25.
  • For EV / EBITDA (X), as of Mar 24, the value is 5.16. This value is within the healthy range. It has increased from 3.78 (Mar 23) to 5.16, marking an increase of 1.38.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 23) to 0.65, marking an increase of 0.28.
  • For Retention Ratios (%), as of Mar 24, the value is 95.27. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 95.27, marking an increase of 95.27.
  • For Price / BV (X), as of Mar 24, the value is 1.44. This value is within the healthy range. It has increased from 0.89 (Mar 23) to 1.44, marking an increase of 0.55.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 23) to 0.65, marking an increase of 0.28.
  • For EarningsYield, as of Mar 24, the value is 0.11. This value is below the healthy minimum of 5. It has decreased from 0.15 (Mar 23) to 0.11, marking a decrease of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of 20 Microns Ltd as of March 12, 2025 is: ₹187.38

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 12, 2025, 20 Microns Ltd is Overvalued by 10.34% compared to the current share price 209.00

Intrinsic Value of 20 Microns Ltd as of March 12, 2025 is: 227.65

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 12, 2025, 20 Microns Ltd is Undervalued by 8.92% compared to the current share price 209.00

Last 5 Year EPS CAGR: 21.49%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 16.83%, which is a positive sign.
  2. The company has higher reserves (168.85 cr) compared to borrowings (137.38 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (511.85 cr) and profit (32.92 cr) over the years.
  1. The stock has a high average Working Capital Days of 66.17, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 82.08, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in 20 Microns Ltd:
    1. Net Profit Margin: 7.2%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 23.69% (Industry Average ROCE: 21.11%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 15.88% (Industry Average ROE: 21.07%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 4.5
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 1.16
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 12 (Industry average Stock P/E: 64.28)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.32
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

20 Microns Ltd. is a Public Limited Listed company incorporated on 29/06/1987 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L99999GJ1987PLC009768 and registration number is 009768. Currently Company is involved in the business activities of Mining/quarrying of limestone, limeshell, ‘kankar' and other calcareous minerals including calcite, chalk and shale. Company's Total Operating Revenue is Rs. 672.45 Cr. and Equity Capital is Rs. 17.64 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
Mining/Minerals9/10, GIDC Industrial Estate, Waghodia, Vadodra District Gujarat 391760co_secretary@20microns.com
http://www.20microns.com
Management
NamePosition Held
Mr. Rajesh C ParikhChairman & Managing Director
Mr. Atil C ParikhManaging Director & CEO
Mrs. Sejal R ParikhWhole Time Director
Mr. Ramkisan A DevidayalIndependent Director
Mr. Atul H PatelIndependent Director
Dr. Ajay I RankaIndependent Director
Mr. Jaideep B VermaIndependent Director
Dr. Sivaram SwaminathanAddnl.Independent Director
Mr. Dukhabandhu RathIndependent Director

FAQ

What is the latest intrinsic value of 20 Microns Ltd?

The latest intrinsic value of 20 Microns Ltd as on 11 March 2025 is ₹187.38, which is 10.34% lower than the current market price of 209.00, indicating the stock is overvalued by 10.34%. The intrinsic value of 20 Microns Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹737 Cr. and recorded a high/low of ₹348/131 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹366 Cr and total liabilities of ₹671 Cr.

What is the Market Cap of 20 Microns Ltd?

The Market Cap of 20 Microns Ltd is 737 Cr..

What is the current Stock Price of 20 Microns Ltd as on 11 March 2025?

The current stock price of 20 Microns Ltd as on 11 March 2025 is ₹209.

What is the High / Low of 20 Microns Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of 20 Microns Ltd stocks is ₹348/131.

What is the Stock P/E of 20 Microns Ltd?

The Stock P/E of 20 Microns Ltd is 12.0.

What is the Book Value of 20 Microns Ltd?

The Book Value of 20 Microns Ltd is 109.

What is the Dividend Yield of 20 Microns Ltd?

The Dividend Yield of 20 Microns Ltd is 0.60 %.

What is the ROCE of 20 Microns Ltd?

The ROCE of 20 Microns Ltd is 21.7 %.

What is the ROE of 20 Microns Ltd?

The ROE of 20 Microns Ltd is 17.8 %.

What is the Face Value of 20 Microns Ltd?

The Face Value of 20 Microns Ltd is 5.00.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in 20 Microns Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE